Suivre
Amarande Murisier
Amarande Murisier
Bioanalytical scientist, PhD in Analytical Pharmaceutical Sciences, Pharmacist
Aucune adresse e-mail validée
Titre
Citée par
Citée par
Année
Therapeutic Fc‐fusion proteins: current analytical strategies
BL Duivelshof, A Murisier, J Camperi, S Fekete, A Beck, D Guillarme, ...
Journal of separation science 44 (1), 35-62, 2021
952021
Tuning selectivity in cation-exchange chromatography applied for monoclonal antibody separations, part 1: Alternative mobile phases and fine tuning of the separation
E Farsang, A Murisier, K Horváth, A Beck, R Kormány, D Guillarme, ...
Journal of pharmaceutical and biomedical analysis 168, 138-147, 2019
372019
Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins
V D'Atri, A Murisier, S Fekete, JL Veuthey, D Guillarme
TrAC Trends in Analytical Chemistry 130, 115962, 2020
342020
Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities
E Wagner, O Colas, S Chenu, A Goyon, A Murisier, S Cianferani, ...
Journal of pharmaceutical and biomedical analysis 184, 113166, 2020
342020
Towards a simple on-line coupling of ion exchange chromatography and native mass spectrometry for the detailed characterization of monoclonal antibodies
A Murisier, BL Duivelshof, S Fekete, J Bourquin, A Schmudlach, ...
Journal of Chromatography A 1655, 462499, 2021
332021
Tuning selectivity in cation-exchange chromatography applied for monoclonal antibody separations, part 2: evaluation of recent stationary phases
A Murisier, E Farsang, K Horváth, M Lauber, A Beck, D Guillarme, ...
Journal of pharmaceutical and biomedical analysis 172, 320-328, 2019
242019
The importance of being metal-free: the critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry
A Murisier, S Fekete, D Guillarme, V D'Atri
Analytica chimica acta 1183, 338987, 2021
182021
Ultra-short ion-exchange columns for fast charge variants analysis of therapeutic proteins
JA Navarro-Huerta, A Murisier, JM Nguyen, MA Lauber, A Beck, ...
Journal of Chromatography A 1657, 462568, 2021
162021
Negative gradient slope methods to improve the separation of closely eluting proteins
S Fekete, A Murisier, JM Nguyen, MA Lauber, D Guillarme
Journal of Chromatography A 1635, 461743, 2021
162021
Using 1.5 mm internal diameter columns for optimal compatibility with current liquid chromatographic systems
S Fekete, A Murisier, GL Losacco, J Lawhorn, JM Godinho, H Ritchie, ...
Journal of Chromatography A 1650, 462258, 2021
142021
Use of ultra-short columns for therapeutic protein separations, Part 2: Designing the optimal column dimension for reversed-phase liquid chromatography
S Fekete, A Murisier, JM Nguyen, MJ Bolton, J Belanger, A Beck, ...
Analytical Chemistry 93 (3), 1285-1293, 2020
132020
Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products
A Murisier, M Andrie, S Fekete, M Lauber, V D'Atri, K Iwan, D Guillarme
Journal of Separation Science 45 (12), 1997-2007, 2022
82022
New wide-pore superficially porous stationary phases with low hydrophobicity applied for the analysis of monoclonal antibodies
S Fekete, A Murisier, A Beck, J Lawhorn, H Ritchie, B Boyes, D Guillarme
Journal of Chromatography A 1642, 462050, 2021
82021
Optimization of MS-Compatible Mobile Phases for IEX Separation of Monoclonal Antibodies.
E Farsang, A Murisier, K Horvath, O Colas, A Beck, D Guillarme, S Fekete
LC-GC Europe 32, 2019
82019
Aptamer-based immunoaffinity LC-MS using an ultra-short column for rapid attomole level quantitation of intact mAbs
JM Nguyen, X Liu, M DeLoffi, A Murisier, S Fekete, D Guillarme, ...
Journal of Chromatography B 1173, 122694, 2021
62021
Practical considerations on the particle size and permeability of ion-exchange columns applied to biopharmaceutical separations
A Murisier, M Lauber, SJ Shiner, D Guillarme, S Fekete
Journal of Chromatography A 1604, 460487, 2019
52019
Hydrophobic interaction chromatography (hic) for the characterization of therapeutic monoclonal antibodies and related products, part 1: Theoretical aspects
S Fekete, A Murisier, D Guillarme
LCGC Europe 34 (3), 101–105-101–105, 2021
42021
Ultra-fast middle-up reversed phase liquid chromatography analysis of complex bispecific antibodies obtained in less than one minute
A Murisier, V D’Atri, S Pirner, V Larraillet, S Fekete, M Lauber, D Guillarme
Pharmaceutics 14 (11), 2315, 2022
32022
Boosting the liquid chromatography separation of complex bispecific antibody products by using the multi-isocratic elution mode
A Murisier, V D’Atri, V Larraillet, S Pirner, D Guillarme
Separations 9 (9), 243, 2022
32022
Hydrophobic Interaction Chromatography (HIC) for the Characterization of Therapeutic Monoclonal Antibodies and Related Products, Part 2: Practical Considerations
S Fekete, A Murisier, L Verscheure, K Sandra, D Guillarme
LCGC Europe 34 (4), 139–148-139–148, 2021
32021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20